Sign in
Home
Media News
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
American Biotech News
Home
Media News
About Us
Contact Us
Home
Tags
Gilead Sciences
Tag: Gilead Sciences
Biotechnology
Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’
-
February 1, 2021
Biotechnology
Draper Aims High as a Kite against Cancer
-
December 16, 2020
Biotechnology
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
-
October 23, 2020
Biotechnology
As FDA OKs Emergency Use, Gilead Commits to “Millions More” Remdesivir...
-
May 4, 2020
Biotechnology
Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline
-
March 2, 2020
Biotechnology
Assessing Coronavirus Impact on Wall Street
-
February 24, 2020
Biotechnology
Gilead Grows Antiviral Pipeline with Novartis, DURECT Licensing Deals
-
July 23, 2019
Edit with Live CSS